Explore

Trendline Trendline
V2X Reports Strong Q1 2026 Financial Results, Increases Full-Year Guidance

V2X Reports Strong Q1 2026 Financial Results, Increases Full-Year Guidance

V2X Reports Strong Q1 2026 Financial Results, Increases Full-Year Guidance
Trendline Trendline
BioMarin Pharmaceutical Prepares for Earnings Report Amid Slower Revenue Growth

BioMarin Pharmaceutical Prepares for Earnings Report Amid Slower Revenue Growth

BioMarin Pharmaceutical Prepares for Earnings Report Amid Slower Revenue Growth
Trendline Trendline
V2X Reports Strong First Quarter 2026 Financial Results and Increases Full-Year Guidance

V2X Reports Strong First Quarter 2026 Financial Results and Increases Full-Year Guidance

V2X Reports Strong First Quarter 2026 Financial Results and Increases Full-Year Guidance
Trendline Trendline
Palantir Technologies Reports Significant Q1 2026 Revenue Growth, Raises Full-Year Guidance

Palantir Technologies Reports Significant Q1 2026 Revenue Growth, Raises Full-Year Guidance

Palantir Technologies Reports Significant Q1 2026 Revenue Growth, Raises Full-Year Guidance
Trendline Trendline
Fabrinet Reports Record Q3 Revenue and Earnings, Exceeds Guidance

Fabrinet Reports Record Q3 Revenue and Earnings, Exceeds Guidance

Fabrinet Reports Record Q3 Revenue and Earnings, Exceeds Guidance
Trendline Trendline
Fabrinet Reports Record Third Quarter Revenue and Earnings, Exceeding Guidance

Fabrinet Reports Record Third Quarter Revenue and Earnings, Exceeding Guidance

Fabrinet Reports Record Third Quarter Revenue and Earnings, Exceeding Guidance
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Expansion Plans

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Expansion Plans

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Expansion Plans
Trendline Trendline
IQVIA Exceeds Q1 Sales Estimates, Raises Full-Year Guidance

IQVIA Exceeds Q1 Sales Estimates, Raises Full-Year Guidance

IQVIA Exceeds Q1 Sales Estimates, Raises Full-Year Guidance
Trendline Trendline
Pfizer Reaffirms 2026 Guidance Amid Strong Q1 Revenue Growth

Pfizer Reaffirms 2026 Guidance Amid Strong Q1 Revenue Growth

Pfizer Reaffirms 2026 Guidance Amid Strong Q1 Revenue Growth
Trendline Trendline
AGCO Reports Strong Q1 2026 Results with Increased Sales and Earnings

AGCO Reports Strong Q1 2026 Results with Increased Sales and Earnings

AGCO Reports Strong Q1 2026 Results with Increased Sales and Earnings
Trendline Trendline
Exxon Mobil and Chevron Surpass Revenue Expectations Despite Profit Decline

Exxon Mobil and Chevron Surpass Revenue Expectations Despite Profit Decline

Exxon Mobil and Chevron Surpass Revenue Expectations Despite Profit Decline